Clinical trial
Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by…
NCT06252870 · Nantes University Hospital, Other · Recruiting
Key facts
| NCT number | NCT06252870 |
|---|---|
| Title | Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation |
| Official title | Randomized Phase 2 Study Testing Two Conditioning Regimen With a Single Prophylaxis of Graft-versus-host Disease by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation |
| Acronym | CY-MET-RIC |
| Lead sponsor | Nantes University Hospital, Other |
| Status | Recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Graft Versus Host Disease, Hematologic Malignancy |
| Intervention type | Drug, Other, Radiation |
| Interventions | Methotrexate, Post-Transplant Cyclophosphamide, Fludarabine, Cycophosphamide, Anti-Thymoglobulin, total body irradiation, hematopoietic stem cells, Graft nuclear cells, Donor Lymphocytes Injection, Clofarabine and 2 more |
| Enrollment | 82 |
| Start date | Jul 18, 2024 |
| Primary completion | Oct 18, 2027 |
| Completion | Jul 18, 2028 |
| First posted | Feb 12, 2024 |
| Last update posted | Jan 26, 2026 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: